Hussman Strategic Advisors Inc. Acquires New Shares in ICU Medical, Inc. (NASDAQ:ICUI)

Hussman Strategic Advisors Inc. acquired a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 12,600 shares of the medical instruments supplier’s stock, valued at approximately $1,955,000. Hussman Strategic Advisors Inc. owned about 0.05% of ICU Medical at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of ICUI. Creative Planning boosted its position in ICU Medical by 58.6% during the third quarter. Creative Planning now owns 6,193 shares of the medical instruments supplier’s stock valued at $1,128,000 after purchasing an additional 2,287 shares during the last quarter. OLD National Bancorp IN bought a new position in ICU Medical during the third quarter valued at about $218,000. Sequoia Financial Advisors LLC bought a new position in ICU Medical during the third quarter valued at about $442,000. Greenleaf Trust bought a new position in ICU Medical during the third quarter valued at about $207,000. Finally, Allworth Financial LP raised its holdings in ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 100 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

Insider Buying and Selling

In related news, CEO Vivek Jain sold 1,373 shares of ICU Medical stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the sale, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at $16,262,119.64. This trade represents a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director David C. Greenberg sold 972 shares of ICU Medical stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total value of $153,682.92. Following the sale, the director now directly owns 5,037 shares in the company, valued at approximately $796,400.07. This trade represents a 16.18 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 17,737 shares of company stock valued at $2,879,752 over the last three months. 6.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on ICUI shares. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. KeyCorp lifted their price objective on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 13th. Finally, Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective on the stock in a research note on Wednesday, December 11th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $199.67.

ICU Medical Trading Up 0.4 %

ICU Medical stock opened at $164.13 on Thursday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The business’s 50-day simple moving average is $160.87 and its 200-day simple moving average is $165.37. The firm has a market capitalization of $4.02 billion, a PE ratio of -35.91 and a beta of 0.63. ICU Medical, Inc. has a 52 week low of $93.36 and a 52 week high of $196.26.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.